High-dose cyclophosphamide in the treatment of severe aplastic anemia in children.
Jaime-Pérez
J C
JC
González-Llano
O
O
Gómez-Almaguer
D
D
D000293:Adolescent; D000741:Anemia, Aplastic / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D002648:Child; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009503:Neutropenia / Q000139:chemically induced / Q000517:prevention & control; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D003520:Cyclophosphamide